JPRN-UMIN000032758Completed未知
Pharmacological cardioversion of nifekalant for ventricular fibliration or tachycardia following reperfuion - Pharmacological cardioversion of nifekalant
Anesgthesiology Service Sakurabashi-Watanabe Hospital0 sites5 target enrollmentStarted: August 28, 2018Last updated:
Trial Snapshot
- Phase
- 未知
- Status
- Completed
- Sponsor
- Enrollment
- 5
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Observational
Eligibility Criteria
- Ages
- 20years-old to 80years-old (—)
- Sex
- All
Inclusion Criteria
- Not provided
Exclusion Criteria
- Not provided
Investigators
Similar Trials
Active, not recruiting
Phase 1
Effects of nebivolol on the cardiovascular functions, thermoregulation and blood flow during real and simulated conditions of microgravity - MISSION Medicine In Space Study - Investigation Of NebivololEUCTR2007-006115-23-FRBerlin-Chemie AG
Recruiting
Phase 3
Evaluation of the effects of the cardioprotective diet on prevention of the incidence of cardiotoxicitycardiotoxicity in patients with breast cancer receiving Anthracycline.Malignant NeoplasmsC00-C97IRCT20131218015860N7School of Traditional Medicine, Traditional Medicine and Materia Medica Research Center,Shahid Behes60
Recruiting
Unknown
Conduct a prospective randomized clinical study on the efficacy and safety of computer modeling for optimal AAD selection in patients with recurrent AF after catheter ablation and evaluate the efficacy and safety of AAD simulations by comparing virtual AAD effect guided therapy and empirical AAD use in patients with recurrent AF after AF catheterization.KCT0008847Yonsei University Health System, Severance Hospital300
Completed
Not Applicable
Hyperemic Efficacy of nicorandil for fractional flow reserve measurement in patients with stable coronary artery diseaseischemic heart diseaseJPRN-UMIN000019309Chiba University Graduate School of Medicine50
Unknown
Phase 3
A comparison of anti-anginal effects of nicorandil (SG-75) with isosorbide mononitrate (ISMN) in patients with stable angina pectoris:A multicenter, randomized, double-blind trial in China.Stable angina pectorisJPRN-jRCT2080220014Chugai Pharmaceutical Co., Ltd.